Clinical Edge Journal Scan

Diabetes and Migraine May Have a Bidirectional Link


 

Key clinical point: Diabetes may have a bidirectional association with migraine risk. Type 1 diabetes (T1D) reduced the risk for migraine, whereas migraine without aura increased the risk for diabetes.

Major findings: Diabetes did not significantly affect the overall risk for migraine (odds ratio [OR], 0.85; P = .13). However, individuals with T1D had a lower risk for migraine (OR, 0.48; P = .002) than those without diabetes. Conversely, migraine did not significantly increase the risk for diabetes (OR, 1.00, P = .99), but individuals with migraine without aura had a higher risk for diabetes (OR, 1.19; P = .03) than those without migraine.

Study details: This meta-analysis included eight cross-sectional studies (131,361 patients with diabetes and 1,005,604 patients with migraine) and four cohort studies (103,205 patients with diabetes and 32,197 patients with migraine).

Disclosure: The study was funded by the Ministry of Health & Welfare, Republic of Korea, and the National Research Foundation of Korea. One author is a junior editor at The Journal of Headache and Pain, and another serves on its board and has received grants from the Korea Health Industry Development Institute.

Source: Ha WS, Nguyen VK, Chu MK. Epidemiological linkage between migraine and diabetes mellitus: A systematic review and meta-analysis. J Headache Pain. 2024;25:158. Source

Recommended Reading

Erenumab Reduces Nonopioid Medication Overuse Headache in Chronic Migraine
Migraine ICYMI
Triptans Outperform Newer Drugs in Acute Treatment of Migraine
Migraine ICYMI
Sustained Remission of Nonopioid Medication Overuse Headache with Erenumab in Chronic Migraine
Migraine ICYMI
Is Telomere Length Linked to Migraine Risk in Younger Adults?
Migraine ICYMI
Galcanezumab Treatment Reduces Central Sensitization Symptoms in Migraine
Migraine ICYMI
Epilepsy May Not Increase Migraine Risk but May Worsen Severity
Migraine ICYMI
Serostatus and Increased Migraine Risk in Patients With Rheumatoid Arthritis
Migraine ICYMI
Ubrogepant Offers Relief From Acute Migraine
Migraine ICYMI
CGRP Inhibitors Outperform Other Migraine-Preventive Medications
Migraine ICYMI
Long-Term Safety of Dihydroergotamine Nasal Powder for Acute Treatment of Migraine
Migraine ICYMI